Can you provide the upcoming earnings date for GLYCOMIMETICS INC?
GLYCOMIMETICS INC (GLYC) will report earnings on 2025-08-06.
GLYCOMIMETICS INC (GLYC) Forecast, Price Target & Analyst Ratings
NASDAQ:GLYC • US38000Q1022
Current stock price
0.157 USD
-0.01 (-5.42%)
At close:
0.1507 USD
-0.01 (-4.01%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for GLYCOMIMETICS INC (GLYC).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- Aug 6, 2025
- Period
- Q2 / 2025
- EPS Estimate
- $0.00
- Revenue Estimate
Price Target Details & History
Consensus Price Target and Range
Mean target
N/A
Upside
N/A
From current price of $0.16 to mean target of N/A, Based on 7 analyst forecasts
Low
N/A
Median
N/A
High
N/A
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
82.86%
GLYC was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about GLYC.
In the previous month the buy percentage consensus was at a similar level.
GLYC was analyzed by 7 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-03-21 | Cantor Fitzgerald | Initiate | Overweight |
| 2024-07-26 | TD Cowen | Downgrade | Buy -> Hold |
| 2024-06-04 | HC Wainwright & Co. | Reiterate | Neutral |
| 2024-05-06 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2024-03-27 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-12-22 | Capital One | Initiate | Overweight |
| 2023-08-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-06-15 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-05-04 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-30 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-02-16 | HC Wainwright & Co. | Maintains | Buy |
| 2022-08-04 | HC Wainwright & Co. | Maintains | Buy |
| 2021-11-12 | Jefferies | Upgrade | Hold -> Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Aug 6, 2025
- Period
- Q2 / 2025
- EPS Estimate
- $0.00
- Revenue Estimate
- Revenue Q2Q
- N/A
- EPS Q2Q
- 100.00%
- Number of Analysts
- 3
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
N/A
Next Earnings Summary
GLYC is expected to report earnings on 8/6/2025. The consensus EPS estimate for the next earnings is 0 USD and the consensus revenue estimate is 0 USD.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.16M -88.58% | 80K -93.10% | 10K -87.50% | -100.00% | 9.588M | 17.952M 87.23% | 130.66M 627.83% | 281.11M 115.15% | |||||
| EBITDA YoY % growth | -63.19M -23.32% | -47.19M 25.32% | -39.122M 17.10% | N/A 16.99% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -63.45M -23.18% | -47.4M 25.30% | -39.275M 17.14% | -33.887M 17.23% | -27.03M 16.85% | -48.96M -81.13% | -96.9M -97.92% | -122.4M -26.32% | -205.53M -67.92% | -238.782M -16.18% | -167.994M 29.65% | -53.04M 68.43% | |
| Operating Margin | -5,469.83% | -59,250.00% | -392,753.00% | N/A | N/A | N/A | N/A | N/A | -2,143.62% | -1,330.11% | -128.57% | -18.87% | |
| EPS YoY % growth | -1.23 -10.81% | -0.88 28.46% | -0.58 34.09% | -0.62 -6.84% | -2.04 -229.22% | -3.06 -50.00% | -3.06 | -0.04 98.67% | -0.05 -25.00% | -0.05 | -0.03 40.00% | -0.01 66.67% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|
| EPS Q2Q % growth | 0.00 100.00% | 0.00 100.00% | 0.00 100.00% |
| Revenue Q2Q % growth | |||
| EBITDA Q2Q % growth | N/A | N/A | N/A |
| EBIT Q2Q % growth | -3.06M 70.46% | -9.18M -60.46% | -11.22M -111.09% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
-74.09%
EPS Next 5 Year
14.05%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
GLYCOMIMETICS INC / GLYC Forecast FAQ
What are the consensus estimates for GLYC stock next earnings?
The consensus EPS estimate for the next earnings of GLYCOMIMETICS INC (GLYC) is 0 USD and the consensus revenue estimate is 0 USD.
How many analysts have analysed GLYCOMIMETICS INC (GLYC)?
The number of analysts covering GLYCOMIMETICS INC (GLYC) is 7.